|Last Price$99.76||Day Change (%)-0.71%|
|Open Price$100.85||Day Change ($)-0.71|
|Day Range99.63–102.00||52-Week Range65.78–105.80|
As of Fri 12/13/2013 01:06 PM EST | USD
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Humana's Third Quarter 2013 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. Later there will be a question-and-answer session.
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX® Peyronie's Disease Data at SMSNA Scientific Meeting
UPDATE: Obamacare fix brings new complications
Humana's growing Medicare business adds value and risk.
After setbacks in the Affordable Care Act's rollout are resolved, we think one 4-star managed care firm is particularly well-positioned to take advantage of the public exchanges over the longer term, says Morningstar's Vishnu Lekraj.
The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...
Week ending August 4